Earnings callsSupriya Lifescience Limited
Every summarised call, newest first. Latest is Q1 FY27, held 14 Aug 2026.
- Q1 FY27Cautious tone
Revenue grew 31% year-on-year, but EBITDA margin contracted to 25% due to temporary water scarcity and one-off solar policy costs, though management remains confident in its full-year revenue and margin guidance.